Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes

Inclusion Criteria: * Type 1 diabetes * Treatment with insulin for at least 6 months prior to inclusion * HbA1c below or equal to 11.0 % * Currently treated with short acting, intermediate acting, long acting human insulin or analogues or a self-mix of these insulins at least 1 month prior to inclusion Exclusion Criteria: * The receipt of any investigational drug within one month prior to this trial * Recurrent severe hypoglycaemia or hypoglycaemic awareness as judged by the investigator * Total daily insulin doses at least 1.80 IU/kg * Treatment with oral hypoglycaemic agents * Known or suspected allergy to trial product or related products